Neurology consultation is the process of medical evaluation of a patient with a neurological disorder by a trained neurologist. It usually involves the neurologist taking a detailed medical history, performing a physical examination, ordering diagnostic tests, and providing a differential diagnosis. In some cases, treatment is initiated at the consultation, but in others, a referral may be made for further evaluation with other specialists or for a more detailed neurologic workup. Neurology consultations are an important part of the diagnosis and treatment process for a range of neurological disorders, including stroke, epilepsy, multiple sclerosis, Parkinson's disease, Alzheimer's disease, traumatic brain injury, peripheral neuropathy, neuromuscular disorders, and sleep disorders. The neurologist may also evaluate and manage behavioral issues, headache, balance disorder, cognitive problems, and dizziness. The neurologist will evaluate the patient’s history, physical examination, and test results to formulate a diagnosis. Diagnostic testing often involves laboratory studies, imaging of the brain or spinal cord, and other neurologic and neurophysiologic tests. Treatment at the consultation will depend on the condition diagnosed and may include medications, lifestyle modifications, physical therapy, occupational therapy, speech therapy, and other interventions. When a neurologist is consulted, it is important that the patient is properly prepared. This includes bringing any medical records, medications, tests results, and a list of any questions that the patient might have about their condition. This helps the neurologist to gain a complete picture of the patient’s history and formulate an appropriate diagnosis and treatment plan. The neurologist may refer the patient to other specialists, such as a physical therapist or occupational therapist to further evaluate and manage their condition. Neurologists may also collaborate with other specialists in providing comprehensive care for the patient.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States